[Thromboembolism complications in neuro- and thymoleptic therapy].
D000293:Adolescent; D000328:Adult; D000639:Amitriptyline / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects*; D002746:Chlorpromazine / Q000009:adverse effects; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007099:Imipramine / Q000009:adverse effects; D008297:Male; D008728:Methotrimeprazine / Q000009:adverse effects; D008875:Middle Aged; D011398:Promethazine / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy*; D012737:Sex Factors; D013881:Thioridazine / Q000009:adverse effects; D013923:Thromboembolism / Q000139:chemically induced*; D014149:Tranquilizing Agents / Q000009:adverse effects*
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D000639:Amitriptyline; D008728:Methotrimeprazine; D011398:Promethazine; D013881:Thioridazine; D007099:Imipramine; D002746:Chlorpromazine
Thromboembolische Komplikationen bei neuro- und thymoleptischer Behandlung.